Patents by Inventor Martin Ashdown

Martin Ashdown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160125125
    Abstract: The present invention relates to computer-implemented methods and system for analysing a biomarker which cycles in a subject. In some other aspects, the present invention relates to analysing a biomarker which at least initially increases or decreases in amount in a subject following a treatment for a disease. In further aspects, the present invention relates to computer-implemented methods and systems for determining a preferred time to administer a therapy to treat a disease in a subject. The present invention also relates to computer program product to implement the methods. Further, the present invention relates to methods of determining the timing of treating a disease in a subject in which the immune system is cycling.
    Type: Application
    Filed: January 12, 2016
    Publication date: May 5, 2016
    Inventors: Martin Ashdown, Andrew Robinson
  • Publication number: 20070202119
    Abstract: Numerous diseases have been linked to the production of regulator cells. The present invention relates to the observation that the immune system is cycling in these diseases. Based on these observations, the present invention provides methods for treating diseases such as cancer and a HIV infection. The present invention also relates to methods of determining when a therapy to treat a disease characterized by the production of regulator cells should be administered to a patient.
    Type: Application
    Filed: October 22, 2004
    Publication date: August 30, 2007
    Inventor: Martin Ashdown
  • Publication number: 20050180971
    Abstract: The present invention provides methods for treating a cancer patient. The methods rely on the observation that cells of the immune system which target a tumor cell (“effector cells”) clonally expand before a population of “regulator” or “suppressor” cells which down-regulate the activity of the immune cells which target the tumor cell. Methods are provided herein which stimulate effector cell production and also provides means for inhibiting the production of, limiting the function of, and/or destroying, regulator cells, in the treatment of cancer.
    Type: Application
    Filed: February 14, 2003
    Publication date: August 18, 2005
    Inventor: Martin Ashdown